Siltuximab and Spartalizumab in Patients With Metastatic Pancreatic Cancer

Conditions:   Metastatic Pancreatic Adenocarcinoma;   Stage IV Pancreatic Cancer AJCC v8 Interventions:   Biological: Siltuximab;   Biological: Spartalizumab Sponsors:   Emory University;   Novartis;   Jazz Pharmaceuticals Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials